How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

110 results for

Hemicrania Continua

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. French Database of Occipital Nerves Stimulation in the Treatment of Refractory Chronic Headache Disorders

headache, chronic paroxysmal hemicranias, SUNCT syndrome, hemicrania continua, cervicogenic headache disorders), and treated by occipital nerves stimulation. Every team using this neuromodulation approach in France is likely to participate in the network. Fifty patients a year are expected. They will be informed about data which are collected and why they are collected. The data will come from medical files and questionnaires filling out by the patients. The data will be collected on a case report form (...) with Conjunctival injection and Tearing), hemicrania continua, cervicogenic headache disorders) according to ICHD-II Criteria Inclusion Criteria: patients suffering from refractory chronic headache disorders and treated by occipital nerves stimulation Exclusion Criteria: patients who don't agree with participating in the study because the ending of professional confidentiality is required for setting up the database Contacts and Locations Go to Information from the National Library of Medicine To learn more

2013 Clinical Trials

62. Safety, Efficacy and Pharmacokinetics of ALD403

Confounding pain syndromes including fibromyalgia, chronic musculoskeletal (e.g., low back pain), psychiatric conditions, dementia, or major neurological disorders other than migraine that interfere with the participation in the trial Diagnosis of complicated migraine, chronic tension-type headache, hypnic headache, hemicrania continua, new daily persistent headache, basilar, hemiplegic, or familial hemiplegic migraine Regular use (greater than 7 days) of prophylactic headache medication (any preventive

2013 Clinical Trials

63. Exercise and Manipulative Therapy for Older Persons With Headache

in extension and rotation and join tenderness in at least one of the upper joint as detected by manual palpation Exclusion Criteria: Headache diagnosed as following: temporal arteritis, trigeminal neuralgia, cluster headache, chronic paroxysmal hemicrania/hemicranias continua, temporomandibular joint dysfunction Other diagnosed disorders: cerebrovascular disease, Parkinson disease, cognitive disturbance Previous history of head or neck surgery Lack of willingness to receive either pragmatic treatment

2012 Clinical Trials

64. Boomerang sign: Clinical significance of transient lesion in splenium of corpus callosum Full Text available with Trip Pro

epilepsy (case 1), localization-related epilepsy (case 2), hemicrania continua (case 3), and postinfectious parkinsonism (case 4). While three patients had complete involvement of the splenium on diffusion-weighted image ("boomerang sign"), the patient having hemicrania continua showed semilunar involvement ("mini-boomerang") on T2-weighted and FLAIR image. All the cases had noncontiguous involvement of the splenium. We herein, discuss these cases with transient splenial involvement and stress

2012 Annals of Indian Academy of Neurology

65. Other primary headaches Full Text available with Trip Pro

syndrome more often has migrainous features or is otherwise has a chronic tension-type headache phenotype. Management is that of the clinical syndrome. Hemicrania continua straddles the disorders of migraine and the trigeminal autonomic cephalalgias and is not dealt with in this review.

2012 Annals of Indian Academy of Neurology

66. 12 minute consultation: Evidence based management of a patient with facial pain. (Abstract)

there had been no nasal symptoms or endoscopic signs of paranasal sinusitis.  This review was based on a literature search performed on 30 November 2011. The MEDLINE, EMBASE and Cochrane databases were searched using the subject heading of facial pain, that is, rhinosinusitis, migraine, cluster headaches, midsegment facial pain, trigeminal neuralgia, paroxysmal hemicrania, hemicrania continua and drug-dependent headache. The search was limited to English language articles. Relevant references from

2012 Clinical Otolaryngology

67. Cluster Headache

continua: Moderately severe continuous unilateral head pain occurs with superimposed brief episodes of more intense pain. Chronic paroxysmal hemicrania and hemicrania continua, unlike SUNCT and cluster headache (and ), respond dramatically to indomethacin , but not to other NSAIDs. Treatment For aborting attacks, parenteral triptans, dihydroergotamine , or 100% oxygen For long-term prophylaxis, verapamil , lithium , topiramate , divalproex, or a combination Acute attacks of cluster headache can (...) unilateral primary headache syndromes with autonomic symptoms, which are sometimes grouped together with cluster headache as trigeminal autonomic cephalgias, should be excluded: (short-lasting unilateral neuralgiform headache with conjunctival injection and tearing): Attacks are very brief (5 to 250 sec) and occur at high frequency (up to 200 attacks/day). Chronic paroxysmal hemicrania: Attacks are more frequent ( > 5/day) and much briefer (usually just minutes) than in cluster headache. Hemicrania

2013 Merck Manual (19th Edition)

68. Approach to the Patient With Headache

. Podcast Pathophysiology Headache is due to activation of pain-sensitive structures in or around the brain, skull, face, sinuses, or teeth. Etiology Headache may occur as a primary disorder or be secondary to another disorder. Primary headache disorders include the following: (including chronic paroxysmal hemicrania, hemicrania continua, and short-lasting unilateral neuralgiform headache with conjunctival injection and tearing—sometimes collectively called trigeminal autonomic cephalalgias) Secondary

2013 Merck Manual (19th Edition)

69. Chronic migraine, classification, differential diagnosis, and epidemiology. (Abstract)

Chronic migraine, classification, differential diagnosis, and epidemiology. Chronic migraine (CM) is the most disabling of the 4 types of primary chronic daily headache (CDH) of long duration, a syndrome defined by primary headaches 15 or more days per month for at least 3 months with attacks that last 4 hours or more per day on average. CDH of long duration includes CM, chronic tension-type headache, new daily persistent headache, and hemicrania continua. CM affects approximately 2

2011 Headache

70. Cluster headache

responsive headache syndromes: Chronic paroxysmal hemicrania and Hemicrania continua. How they were discovered and what we have learned since". Functional Neurology . 25 (1): 49–55. . Rizzoli, P; Mullally, WJ (September 2017). "Headache". American Journal of Medicine (Review). S0002-9343 (17): 30932–4. : . . Benoliel, Rafael (2012). . British Journal of Pain . 6 (3): 106–23. : . . . ^ May, A.; Leone, M.; Áfra, J.; Linde, M.; Sándor, P. S.; Evers, S.; Goadsby, P. J. (2006). "EFNS guidelines (...) hemicrania may also be episodic but the episodes of pain seen in CPH are usually shorter than those seen with cluster headaches. CPH typically responds "absolutely" to treatment with the drug where in most cases CH typically shows no positive indomethacin response, making "Indomethacin response" an important diagnostic tool for specialist practitioners seeking correct differential diagnosis between the conditions. (SUNCT) is a headache syndrome belonging to the group of TACs. is a unilateral headache

2012 Wikipedia

71. Nutrition for Chronic Daily Headache

of a neurologist willing and able to document headache characteristics and use of medications, as well as complete the assessment instruments able to come in for 3 dietitian-administered dietary counseling sessions over 12 weeks able to speak and understand English Exclusion Criteria: analgesic rebound headache hemicrania continua drug-induced headache post-traumatic headache significant, symptomatic uncontrolled psychosis undergoing current treatment for a major medical illness such as malignancy, autoimmune

2010 Clinical Trials

72. Efficacy and Safety of Cyclobenzaprine Hydrochloride Extended Release for the Treatment of Chronic Migraine

. women of childbearing potential must use an acceptable method of birth control for the duration of the study (oral contraceptives, IUD, injectable or intravaginal contraception or barrier methods combined with spermicide) Exclusion Criteria: subjects <18 and >65 years of age pregnancy or attempted pregnancy during the study nursing females psychiatric condition which, in the investigator's opinion will influence trial safety or data collection new daily persistent headache, hemicrania continua

2010 Clinical Trials

73. Epidemiological classification and social impact of chronic headache. (Abstract)

Epidemiological classification and social impact of chronic headache. The current prevalent opinion is that a diagnosis of chronic headache should be established in patients who have had a form of primary headache other than cluster headache on at least 15 days a month for at least 3 months. Chronic headache so defined includes four different subtypes: hemicrania continua and new daily persistent headache--two rare forms currently included in the group "Other primary headaches" of the 2004

2010 Internal and emergency medicine

74. Greater Occipital Nerve Block for Migraine Prophylaxis

hypersensitivity or allergic reaction to any of study ingredients (lidocaine, bupivicaine, any local anesthetics, and corticosteroids) or betadine. Use of any investigational medication within 90 days of the initial screening visit and/or concurrent enrolment in an investigational study Injection site infection or systemic infection at the injection visit (afebrile at time of injection) Presence of cranial bone defect Subjects with chronic cluster headache, new daily persistent headache, hemicrania continua

2009 Clinical Trials

75. Diagnostic delay and suboptimal management in a referral population with hemicrania continua. (Abstract)

Diagnostic delay and suboptimal management in a referral population with hemicrania continua. To investigate a clinical population of patients with hemicrania continua (HC), looking at the diagnostic problems they have encountered and their use of healthcare resources and at issues relating to the effectiveness of treatments.We directly interviewed 25 patients fulfilling the International Classification of Headache Disorders, 2nd edition diagnostic criteria for HC selected among 1612 subjects (...) (24%) were the most commonly used. Patients rated 73.7% of medications as ineffective, 22.5% (all NSAIDs) as partially effective, and 3.7% (rofecoxib and nimesulide) as effective.Hemicrania continua may be misdiagnosed and mistreated even by neurologists. There is a need for greater awareness and understanding of this condition.

2009 Headache

76. A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches

Diagnosis of complicated migraine, chronic tension-type headache, hypnic headache, hemicrania continua, new daily persistent headache Use of prophylactic headache medication within 28 days prior to week -4 Unremitting headache lasting continuously throughout the 4-week baseline period Known or suspected TMD Diagnosis of fibromyalgia Beck depression inventory score >24 at week-4 Psychiatric problems that may have interfered with study participation Contacts and Locations Go to Information from

2005 Clinical Trials

77. A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches

at increased risk with exposure to BOTOX Diagnosis of complicated migraine, chronic tension-type headache, hypnic headache, hemicrania continua, new daily persistent headache Use of prophylactic headache medication within 28 days prior to week -4 Unremitting headache lasting continuously throughout the 4-week baseline period Known or suspected Temporomandibular Disorders (TMD) Diagnosis of fibromyalgia Beck depression inventory score >24 at week-4 Psychiatric problems that may have interfered with study

2005 Clinical Trials

78. Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?

: No Criteria Inclusion Criteria: fulfill 8.2.7 probably medication-overuse headache according to the International Classification of headache disorders, 2th Edition (2004) Exclusion Criteria: No benefit of all available preventative medications, no benefit of abrupt withdrawal lasting more than 3 weeks of acute medication that has been overused, cluster headache, CPH or hemicrania continua, pregnant, use of pain killers of other reasons than headache, other reasons for chronic daily headache than

2005 Clinical Trials

79. Prevalence of Phonophobia and Cutaneous Allodynia in Episodic Migraineurs

or less at the frequency range of 200-8000Hz.). Exclusion criteria for migraine subjects: Any other headache diagnosis (e.g. cluster headache, hemicrania continua, post traumatic headache, etc.) except for episodic tension type headache (ETTH) with an average of no more than 10 ETTH headache days per month for the 6 months prior to enrollment (note: average <15 total HA days is specified in inclusion) Use of any headache preventive drug (determined by investigator) in the 90 days prior to screening

2006 Clinical Trials

80. The prophylactic treatment of chronic daily headache. (Abstract)

The prophylactic treatment of chronic daily headache. Chronic daily headache (CDH), a heterogeneous group of headache disorders occurring on at least 15 days per month, affects up to 4% to 5% of the general population. CDH disorders include transformed (or chronic) migraine, chronic tension-type headache, new daily persistent headache, and hemicrania continua. Patients with CDH have greater disability and lower quality of life than episodic migraine patients and often overuse headache pain

2006 Headache

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>